Clinical Trial Update: A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics of certolizumab pegol in adults with active rheumatoid arthritis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2023-11-13